泽纳斯生物制药

最新新闻

• 评级变动
  Analysts Offer Insights on Healthcare Companies: Zenas BioPharma, Inc. (ZBIO) and Atai Beckley N.V. (ATAI)
  TipRanks · 2026/6/27
• 评级变动
  Analysts' Top Healthcare Picks: Zenas BioPharma, Inc. (ZBIO), Entrada Therapeutics Inc (TRDA)
  TipRanks · 2026/6/3
• 评级变动
  Analysts Are Bullish on Top Healthcare Stocks: Alpha Cognition Inc (ACOG), Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/6/11
• 评级变动
  Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/8/14
• 评级变动
  Wedbush Initiates Zenas BioPharma(ZBIO.US) With Buy Rating, Announces Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  Wedbush Sticks to Its Buy Rating for Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/5/14
• 评级变动
  Zenas BioPharma, Inc. (ZBIO) Receives a Buy From Guggenheim
  TipRanks · 2026/8/14
• 评级变动
  Guggenheim Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $55
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Hold Rating, Raises Target Price to $32
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  Wedbush Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/8/14
• 评级变动
  Citi Sticks to Its Buy Rating for Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/9/11
• Wedbush Remains a Buy on Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/9/30
• 评级变动
  Morgan Stanley Reaffirms Their Hold Rating on Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/8/14
• 评级变动
  Citi Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $41
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• H.C. Wainwright Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $44
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  H.C. Wainwright Keeps Their Buy Rating on Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/9/22
• 评级变动
  Wedbush Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• Citi Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• Analysts Are Bullish on Top Healthcare Stocks: DocGo (DCGO), Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/9/30
• Citi Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Raises Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/9/30

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。